Market Tracker

09/19 7:35am ET

Galectin Therapeutics Inc (NASDAQ:GALT)

5.57
Data as of Sep 18
 -0.16 / -2.79%
Today’s Change
4.28
Today|||52-Week Range
19.11
-31.06%
Year-to-Date

Today’s Trading

Previous close5.73
Today’s open5.77
Day’s range-- - --
Volume277,993
Average volume (3 months)767,635
Market cap$122.5M
Dividend yield--
Data as of 09/18/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-33.10%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd+0.67+7.26%
TROVTrovagene Inc-0.14-2.58%
ERBERBA Diagnostics Inc-0.17-4.83%
CGIXCancer Genetics Inc-0.06-0.70%
Data as of 09/18/2014

Financials

Next reporting dateNovember 13, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts